Rhythm Pharmaceuticals

IPO

Pioneering a path forward for patients and families.

Rhythm Pharmaceuticals is a biotech company in Boston, United States, founded in 2010. It has raised $398.0M across 4 rounds, most recently a $175.0M Extension Round in July 2025.

Employees
201–500
Founded
2010
Business Model
B2B
Total Funding
$398.0M
Last Round
$175.0M Extension RoundJul 2025
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 3 investors for this company. to use credits for reveals, or explore the API.

About

Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on transforming the lives of patients with rare neuroendocrine diseases. The company develops precision medicines addressing the root cause of diseases driven by the melanocortin-4 receptor (MC4R) pathway, including its lead asset IMCIVREE (setmelanotide) approved for rare genetic obesity disorders such as Bardet-Biedl syndrome and POMC deficiency. Rhythm trades on Nasdaq under the ticker RYTM.

Funding & Exit History

Data from Indexed.vcUpdated
Extension RoundPublic Offering (Extension)Jul 2025
$175.0M

4 more events

  • Convertible2024
  • IPO2017
  • Series B20121 investor

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×3
  • Cloud/Infrastructure ×1
  • Other ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Rhythm Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/rhythm-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/rhythm-pharmaceuticals" alt="Rhythm Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>